A RANDOMIZED, MULTICENTER, OPEN-LABEL, PHASE III TRIAL COMPARING TRASTUZUMAB PLUS

Administered By

Duke Cancer Institute

Contributors

Marcom, Paul Kelly Principal Investigator

Start/End

September 1, 2014 - August 31, 2020